A revolutionary new treatment for cataracts

has been gaining in popularity here in Europe since it was featured over in the UK on the Richard & Judy Television Show last year with amazing results. Ethos GmbH Schweiz, the Swiss manufacturers, claim 'This could mean an end to cataract surgery'.

The product, called Ethos Endymion "Bright Eyes", uses a special derivative of the naturally occurring neuropeptide L-Carnosine, called N-Acetyl-Carnosine (NAC), which is a super antioxidant and anti-glycating agent. NAC, when topically applied, can penetrate and protect the lipid tissues of the eye against light damage and also helps to diminish free radical damage and the harmful effects of glycosylation associated with degenerative eye disease.

Professor Steven Charles Gallant, the world renowned biochemist who was originally responsible for introducing Bright Eyes to Europe says; "I have been studying the effects of L-Carnosine for many years. It was first discovered back in 1988 that N-Acetyl-Carnosine had positive effects on cataracts. My father had cataracts and did not relish going under the knife so I tried to get some for him but unfortunately, at the time, it wasn't easily obtainable. My father had to have the operation, which thankfully was successful. But that got me to thinking how great it would be if we were to develop, and make readily available, a product whereby this condition could be addressed with a simple course of eye drops as opposed to invasive surgery. After many years' research, development and trials of Bright Eyes, many people are now enjoying much-improved vision due to this exciting medical breakthrough."